Hospital del Mar
Barcelona, 08003, Spain
NCT Number: NCT02630160
A randomized double-blind clinical trial was performed. There were 4 groups according to catheter placement and infusion constituents: 1) Intraarticular catheter + anesthetics; 2) Intraarticular catheter +placebo; 3) Subfascial catheter + anesthetics; 4) Subfascial catheter + placebo. The anesthetics infusion contained bupivacaine (bolus + continuous perfusion up to 36 hours). The placebo solution consisted in physiological serum (bolus + continuous perfusion up to 36 hours). Randomization was performed in the hospital pharmacy and the surgeon kept out the surgical field when the resident placed the catheter. The same conventional analgesic schedule was prescribed to all patients: PCA (patient controlled analgesia) + paracetamol 1g/6h + dexketoprofen 50mg/12h. The pain was evaluated by means of PCA (patient controlled analgesia) shots and the VAS (visual analog scale). Side effects, time to start rehabilitation and time to discharge were also analyzed. A statistical analysis was performed to compare all this variables between the 4 groups (SPSS 18.0).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Barcelona, 08003, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intraarticular infusion with bupivacaine
Other names: Bupivacaine / epinephrine, Vivacaine
Intraarticular infusion physiological serum
Other names: Flebobag Salina Fisiologica Grifols 0.9%
Time frame: 36 hours
Visual analog pain scale score every eight hours for 36 hours postoperatively
Parc de Salut Mar
Other
Acronym: ILIACPCPTHR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsNCT04543097
Absence, Behavior
Newcastle-under-Lyme, United Kingdom
View Trial DetailsNCT02822989
Autoimmune Diseases, Connective Tissue Diseases
Manhasset, New York, United States
View Trial DetailsNCT04441619
Muscular Diseases, Musculoskeletal Diseases
Gainesville, Florida, United States
View Trial Details